CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ReproCell Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ReproCell Inc
9F, KDX Shin-Yokohama 381 Bldg.
3-8-11, Shin-Yokohama, Kohoku-ku
Phone: +81 454753887p:+81 454753887 YOKOHAMA-SHI, KNG  222-0033  Japan Ticker: 49784978
Business Summary
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clinical testing services that is required by hematopoietic stem cell transplantation and organ transplantation.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
8734 Testing laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chairman of Subsidiaries, Representative Director ChikafumiYokoyama 45 10/1/2020 1/1/2011
Chief Financial Officer, General Manager of Business Administration Unit SatoshiMunemura 41 4/1/2023 4/1/2023
Chief Operating Officer, Director DaisukeUsui 48 11/1/2020 11/1/2020
Director ShigetomoAkano 41 4/1/2023 11/1/2020
Independent Director YoshiyukiYamakawa 60 6/1/2008 6/1/2008

Subsidiaries
Business Name Address City State/Province Country
ReproCELL Europe Ltd. West of Scotland Science Park Glasgow United Kingdom
BioServe Biotechnologies, Ltd. 9000 Virginia Manor Road Beltsville MD United States

Business Names
Business Name
4978
BioServe Biotechnologies (India) Private Limited
BioServe Biotechnologies, Ltd.
4 additional Business Names available in full report.

General Information
Number of Employees: 92 (As of 3/31/2023)
Outstanding Shares: 88,152,435 (As of 2/28/2024)
Shareholders: 37,813
Stock Exchange: TYO
Federal Tax Id: 000007692
Fax Number: +81 454741006


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024